國立高雄大學圖資館 |

Language: English

Back

Translational research methods for d...

Heinemann, Lutz.

Translational research methods for diabetes, obesity and cardiometabolic drug developmenta focus on early phase clinical studies /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Translational research methods for diabetes, obesity and cardiometabolic drug developmentedited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch.
Reminder of title:	a focus on early phase clinical studies /
other author:	Krentz, Andrew J.
Published:	London :Springer London :2015.
Description:	xii, 312 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Drug development.
Online resource:	http://dx.doi.org/10.1007/978-1-4471-4920-0
ISBN:	9781447149200 (electronic bk.)

Translational research methods for diabetes, obesity and cardiometabolic drug developmenta focus on early phase clinical studies /
Translational research methods for diabetes, obesity and cardiometabolic drug developmenta focus on early phase clinical studies /[electronic resource] :edited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch. - London :Springer London :2015. - xii, 312 p. :ill., digital ;24 cm.

1. Review of physiology/pathophysiology -- 2. Methods for assessing insulin action in humans -- 3. Assessment of insulin secretion -- 4. Measurement of ectopic fat in liver and muscle using magnetic resonance spectroscopy -- 5. Isotopic tracers for the measurement of metabolic flux -- 6. Measuring food intake in clinical drug development -- 7. Measurement of energy expenditure -- 8. Assessment of body composition -- 9. Assessment of cardiovascular safety of new diabetes drugs.

This book aims to aid the selection of the most appropriate techniques for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, and related cardiometabolic disease. Clinical research methods for assessing the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g. the euglycaemic clamp technique, have become well-established in proof-of-mechanism studies; however, selection of the best techniques is by no means straightforward. This book will aid the understanding of the need for new pharmacotherapies for type 1 diabetes, type 2 diabetes, and obesity and the molecular targets of drugs currently in development. Emerging technologies including the omics disciplines are considered together with practical and ethical issues of early phase clinical trials in subjects with cardiometabolic disorders. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development will be of interest to biomedical scientists, pharmacologists, academics involved in metabolic research and clinicians practicing in these specialties.

ISBN: 9781447149200 (electronic bk.)

Standard No.: 10.1007/978-1-4471-4920-0doiSubjects--Topical Terms:

190608
Drug development.

LC Class. No.: RM301.25

Dewey Class. No.: 615.19

Translational research methods for diabetes, obesity and cardiometabolic drug developmenta focus on early phase clinical studies /
LDR:02606nmm a2200313 a 4500 001 460746
003 DE-He213
005 20150722094808.0
006 m d
007 cr nn 008maaau
008 151110s2015 enk s 0 eng d
020 $a 9781447149200 (electronic bk.)
020 $a 9781447149194 (paper)
024 7 $a 10.1007/978-1-4471-4920-0 $2 doi
035 $a 978-1-4471-4920-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a MB $2 bicssc
072 7 $a MED000000 $2 bisacsh
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .T772 2015
245 0 0 $a Translational research methods for diabetes, obesity and cardiometabolic drug development $h [electronic resource] : $b a focus on early phase clinical studies / $c edited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch.
260 $a London : $b Springer London : $b Imprint: Springer, $c 2015.
300 $a xii, 312 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Review of physiology/pathophysiology -- 2. Methods for assessing insulin action in humans -- 3. Assessment of insulin secretion -- 4. Measurement of ectopic fat in liver and muscle using magnetic resonance spectroscopy -- 5. Isotopic tracers for the measurement of metabolic flux -- 6. Measuring food intake in clinical drug development -- 7. Measurement of energy expenditure -- 8. Assessment of body composition -- 9. Assessment of cardiovascular safety of new diabetes drugs.
520 $a This book aims to aid the selection of the most appropriate techniques for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, and related cardiometabolic disease. Clinical research methods for assessing the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g. the euglycaemic clamp technique, have become well-established in proof-of-mechanism studies; however, selection of the best techniques is by no means straightforward. This book will aid the understanding of the need for new pharmacotherapies for type 1 diabetes, type 2 diabetes, and obesity and the molecular targets of drugs currently in development. Emerging technologies including the omics disciplines are considered together with practical and ethical issues of early phase clinical trials in subjects with cardiometabolic disorders. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development will be of interest to biomedical scientists, pharmacologists, academics involved in metabolic research and clinicians practicing in these specialties.
650 0 $a Drug development. $3 190608
650 0 $a Diabetes $x Treatment. $3 276740
650 0 $a Obesity $x Treatment. $3 249056
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Medicine/Public Health, general. $3 273879
650 2 4 $a Internal Medicine. $3 273839
650 2 4 $a Diabetes. $3 274215
650 2 4 $a Metabolic Diseases. $3 274217
650 2 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
700 1 $a Krentz, Andrew J. $3 615023
700 1 $a Heinemann, Lutz. $3 712371
700 1 $a Hompesch, Marcus. $3 712372
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-1-4471-4920-0
950 $a Medicine (Springer-11650)